Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rimabotulinumtoxinB (Myobloc) (1 trial)
Cerebral Palsy (Phase 1)
Muscle Spasticity (Phase 1)
Trials (1 total)
Trial APIs (1 total)